Tian An Medicare (STU:SMI) ROCE % : 5.02% (As of Jun. 2024)

View and export this data going back to . Start your Free Trial

What is Tian An Medicare ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Tian An Medicare's annualized ROCE % for the quarter that ended in Jun. 2024 was 5.02%.

Tian An Medicare ROCE % Historical Data

The historical data trend for Tian An Medicare's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tian An Medicare ROCE % Chart

Tian An Medicare Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

1.67

-2.06

-2.43

-2.83

3.58

Tian An Medicare Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
ROCE %	Get a 7-Day Free Trial															-0.73	-4.91	3.00	4.19	5.02

Tian An Medicare ROCE % Calculation

Tian An Medicare's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	9.77	/	( ( (391.953 - 137.102)	+	(424.742 - 134.427) )	/ 2 )
	=	9.77	/	( (254.851	+	290.315)	/ 2 )
	=	9.77	/	272.583
	=	3.58 %

Tian An Medicare's ROCE % of for the quarter that ended in Jun. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Jun. 2024 )		(Q: Dec. 2023 )		(Q: Jun. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Jun. 2024 )		(Q: Dec. 2023 )		(Q: Jun. 2024 )
	=	14.7	/	( ( (424.742 - 134.427)	+	(414.103 - 118.5) )	/ 2 )
	=	14.7	/	( ( 290.315	+	295.603 )	/ 2 )
	=	14.7	/	292.959
	=	5.02 %

(1) Note: The EBIT data used here is two times the semi-annual (Jun. 2024) EBIT data.

Tian An Medicare (STU:SMI) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Tian An Medicare ROCE % Related Terms

Thank you for viewing the detailed overview of Tian An Medicare's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Tian An Medicare Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Tian An Medicare Ltd (STU:SMI) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

00383:Hong Kong

Address

333 Lockhart Road, 47th Floor, United Asia Finance Centre, Wanchai, Hong Kong, HKG

Website

http://www.tiananmedicare.com.hk

Tian An Medicare Ltd is an investment holding company and operator of integrated healthcare and eldercare services. Its main focus is on the investment, management and operations of healthcare and eldercare businesses, and the related property investment and development, and comprehensive spectrum of healthcare and eldercare services to customers in the People's Republic of China ("PRC") and Asia Pacific. The Group is also involved in businesses of securities trading and investment, and provision of financial services.